2025-01-30 - Analysis Report
## Merck & Co Inc (MRK) Stock Report

**1. Performance Comparison and Divergence:**

Merck & Co Inc (MRK), a leading pharmaceutical company, has shown a cumulative return of 62.25% over the analyzed period.  Compared to the S&P 500 (VOO) with a cumulative return of 119.94%, MRK underperformed by 57.7 percentage points.  The relative divergence of -57.7 places it at the 5.9th percentile of its historical range of divergence from the S&P 500, indicating consistent underperformance relative to the market index.

**Alpha/Beta Analysis:** The provided data shows inconsistent performance relative to the market (negative alpha), with high beta suggesting high volatility and correlation to market movements.  The significant fluctuations in CAGR and MDD (Maximum Drawdown) highlight the risk associated with the investment.

**2. Recent Price Movement:**

* **Closing Price:** $98.28
* **5-Day Moving Average:** $97.17
* **20-Day Moving Average:** $98.66
* **60-Day Moving Average:** $99.39

The price is slightly below its 20-day and 60-day moving averages, suggesting a potential short-term bearish trend.  The recent price increase (+$0.85) from the previous close indicates a slight positive momentum.

**3. Technical Indicators and Expected Return:**

* **RSI:** 41.77 (Below 50, suggesting bearish momentum)
* **PPO:** -0.0803 (Negative, indicating bearish momentum)
* **Delta_Previous_Relative_Divergence:** +5.7 (Indicates short-term upward price movement)
* **Expected Return:** 108.8% (This figure represents the projected excess return over the S&P 500 for long-term (2+ years) investment.  This high expected return should be viewed with caution due to inherent uncertainty in long-term projections.  The data doesn't show the methodology used to calculate this expected return and therefore requires further investigation and independent validation.)

The recent price increase might be considered a short-term bounce, given the RSI and PPO values, which suggest the overall trend remains bearish.  Further analysis is needed to confirm the sustainability of this upward movement.

**4. Recent Earnings Analysis:**

The provided earnings data shows fluctuation in EPS and revenue. While some quarters show high EPS values, there is no clear upward trend.  More data points are needed for a robust trend analysis.  Note also that the data shows duplicate entries for 2024-11-06. Data cleaning and verification are necessary before drawing conclusions.


| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-11-06 | 1.25 | $16.66 B    |
| 2024-08-05 | 2.15 | $16.11 B    |
| 2024-05-03 | 1.88 | $15.78 B    |
| 2023-11-03 | 1.87 | $15.96 B    |
| 2024-11-06 | 1.87 | $15.96 B    |


**5. Financial Information:**

The financial data shows relatively stable revenue but fluctuating profitability.  Profit margins appear healthy, generally exceeding 70%. ROE exhibits significant variability, with a negative value in Q4 2023, suggesting potential challenges in capital utilization during that period. Further analysis is needed to understand the drivers of these fluctuations.


**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2024-09-30 | $16.66B    | 75.51%        |
| 2024-06-30 | $16.11B    | 76.76%        |
| 2024-03-31 | $15.78B    | 77.56%        |
| 2023-12-31 | $14.63B    | 73.26%        |
| 2023-09-30 | $15.96B    | 73.29%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2024-09-30 | $44.50B    | 7.09%   |
| 2024-06-30 | $43.58B    | 12.52%  |
| 2024-03-31 | $40.36B    | 11.80%  |
| 2023-12-31 | $37.58B    | -3.26%  |
| 2023-09-30 | $41.25B    | 11.50%  |



**7. Overall Analysis:**

MRK's performance has lagged the S&P 500 significantly. While the company shows healthy profit margins and revenue, inconsistent earnings and fluctuating ROE raise concerns.  The short-term price movement indicates potential for a short-term bounce, but bearish technical indicators suggest a cautious outlook.  The high projected long-term expected return needs further scrutiny and independent validation before relying on it for investment decisions.  A thorough due diligence, including a deeper dive into the drivers of financial performance fluctuations, is recommended before making any investment decisions.  The data provided requires further cleaning and verification before a complete and robust analysis can be conducted.

**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investment decisions should be made based on thorough research and consultation with a qualified financial advisor.
